What condition is conduction system pacing particularly aimed to treat or prevent?

Conduction system pacing is particularly aimed at treating or preventing pacing-induced cardiomyopathy, which can occur in patients who require pacemakers. In traditional pacing methods, leads are placed in the right atrium and right ventricle, which can result in asynchronous contraction of the heart and negatively impact its efficiency. This asynchronous beating can lead to heart muscle dysfunction over time, known as pacing-induced cardiomyopathy.

By contrast, conduction system pacing targets the heart's natural conduction system directly, specifically the His bundle or the left bundle branch. This approach promotes more physiological activation of the ventricles, improving the heart's efficiency and maintaining proper rhythm. Consequently, it significantly reduces the risk of developing pacing-induced cardiomyopathy, offering better long-term outcomes for patients requiring pacing support.

In this context, the other conditions mentioned—high cholesterol, hypertension, and gastroesophageal reflux disease—do not relate directly to the objectives of conduction system pacing, as they pertain to different health issues that aren't primarily addressed by modifications in pacing strategies.